Associations among domains of self-disturbance in schizophrenia

Psychiatry Res. 2018 Sep:267:187-194. doi: 10.1016/j.psychres.2018.05.082. Epub 2018 Jun 6.

Abstract

Self-disturbances are increasingly recognized as important, possibly even central, features of schizophrenia. However, little is known about the associations among different manifestations of self-disturbances. The aims of the current study were threefold. We aimed to (1) replicate previous findings of increased self-disturbances in schizophrenia, (2) correlate manifestations of self-disturbances in schizophrenia across three domains, and (3) correlate self-disturbances with five symptoms domains of schizophrenia, including positive, negative, disorganized symptoms, excitement, and emotional distress. We examined three domains of self-experience, including somatosensation, anomalous self-experiences, and self-concept clarity. Participants included 48 individuals with schizophrenia and 36 non-psychiatric controls. The results of this study replicate previous findings of significantly higher levels of self-disturbances in people with schizophrenia. The results also indicate positive correlations between the domains of anomalous self-experiences and self-concept clarity, but not somatosensation, in individuals with schizophrenia. As well, anomalous self-experiences were positively correlated with positive symptoms, disorganized symptoms, and emotional distress and self-concept clarity was negatively correlated with disorganized symptoms and emotional distress.

Keywords: Anomalous self-experience; Self-concept clarity; Somatosensation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antipsychotic Agents / therapeutic use
  • Emotions
  • Female
  • Humans
  • Male
  • Schizophrenia / diagnosis*
  • Schizophrenia / drug therapy
  • Schizophrenia / epidemiology
  • Schizophrenic Psychology*
  • Self Concept*
  • Somatosensory Disorders / diagnosis
  • Somatosensory Disorders / drug therapy
  • Somatosensory Disorders / epidemiology

Substances

  • Antipsychotic Agents